Clinical Trial Update: Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT [Phase 4]

View source ↗

Summary

Phase 4 study evaluating two interferon-gamma release assays (QuantiSPOT) for diagnosing latent tuberculosis in HIV-infected patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Latent Tuberculosis Infection

Drugs mentioned

• QuantiSPOT Interferon-γ release assay (Interferon-gamma release assay)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections, Tuberculosis | Phase 4 | Status: COMPLETED